Research ArticleOsteoarthritis

A randomized clinical efficacy study targeting mPGES1 or EP4 in dogs with spontaneous osteoarthritis

See allHide authors and affiliations

Science Translational Medicine  30 Oct 2019:
Vol. 11, Issue 516, eaaw9993
DOI: 10.1126/scitranslmed.aaw9993

Article Information

vol. 11 no. 516

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication February 15, 2019
  • Accepted for publication October 11, 2019
  • .

Author Information

  1. Carol Robertson-Plouch1,*,
  2. John R. Stille1,,
  3. Peng Liu1,,
  4. Claire Smith2,§,
  5. Dorothy Brown3,4,
  6. Margaret Warner1,
  7. Leijun Hu1 and
  8. Matthew J. Fisher1
  1. 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.
  2. 2Eli Lilly and Company, Erl Wood Manor, Windlesham, Surrey GU20 6PH, UK.
  3. 3Elanco, Eli Lilly and Company, Indianapolis, IN 46140, USA.
  4. 4School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  1. Corresponding author. Email: Stille_john_r{at}lilly.com
  • * Present address: Convergence Bioscience LLC, Greenfield, IN 46140, USA.

  • Present address: Alexion Pharmaceuticals Ltd., New Haven, CT 06510, USA.

  • § Present address: Smith Statistics Ltd., London EC4M 9BJ, UK.

Altmetric

Article usage

Article usage: October 2019 to October 2020

AbstractFullPdf
Oct 2019822109179
Nov 20192050333219
Dec 20199645744
Jan 20208138827
Feb 20207816619
Mar 202036210325
Apr 20201138630
May 202074459
Jun 2020584815
Jul 2020784911
Aug 202040559
Sep 2020897015
Oct 2020374115

Stay Connected to Science Translational Medicine